Humanitas SpA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Humanitas SpA - overview
Established
1988
Location
Milan, -, Italy
Primary Industry
Healthcare
About
Humanitas SpA is a specialized healthcare institution based in Milan, Italy, dedicated to providing advanced medical services, including diagnostics, treatment, and research across various specialties such as oncology and cardiology. Founded in 1988, Humanitas SpA operates as a high-specialization medical institution in Milan, Italy, primarily focusing on healthcare and research. The company has not undergone significant pivots or changes in business operations since its inception. Luciano Ravera is the CEO, and he leads the institution's efforts in delivering comprehensive medical services.
The hospital has been involved in 2 deals, with the most recent occurring on December 23, 2005, when it was sold to Centrobanca and Techint Group for an undisclosed amount. Humanitas Research Hospital offers a wide array of healthcare services, including diagnosis, treatment, and research, particularly in oncology, cardiology, neurology, orthopedics, and fertility. The hospital operates specialized centers, including the Cancer Center, Cardio Center, and Fertility Center, and supports research through over 400 researchers employing advanced technologies such as two-photon microscopy. The institution serves a diverse client base, focusing on the Italian market while also attracting international patients seeking specialized medical care.
In 2023, Humanitas Research Hospital reported a revenue of EUR 640. 03 mn and an EBITDA of EUR 77. 53 mn. The hospital's revenue is generated through direct patient services and partnerships with insurance providers, operating on a fee-for-service model that includes various medical transactions.
Looking ahead, Humanitas SpA plans to introduce new medical technologies and services aimed at enhancing patient care. The institution is targeting expansion into additional European markets by 2025, leveraging recent investments to support these initiatives. The funding received will be utilized for developing new programs and enhancing its research capabilities, positioning the hospital for future growth opportunities.
Primary Industry
Healthcare
Sub Industries
Hospitals
Website
www.humanitas.it
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Humanitas SpA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Humanitas SpA | - | ||||||||
| Buyout | Completed | Humanitas SpA | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.